These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29076696)

  • 1. Visceral Leishmaniasis In Adults.
    Idris M; Farid J; Gul N; Ahmed F; Irshad R
    J Ayub Med Coll Abbottabad; 2017; 29(3):509-510. PubMed ID: 29076696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral leishmaniasis: adult population of Abbottabad at risk now.
    Idris M; Farid J; Gul N; Anis-ur-Rehman
    J Ayub Med Coll Abbottabad; 2010; 22(2):214-5. PubMed ID: 21702307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Hematological Features of Visceral Leishmaniasis at Mymensingh Medical College Hospital.
    Malek MS; Robi IH; Islam MS; Kabir MA; Uddin MZ; Sumon SM; Siddiqui NI
    Mymensingh Med J; 2020 Oct; 29(4):879-886. PubMed ID: 33116091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphology Of Bone Marrow In Visceral Leishmaniasis.
    Idris M; Farid J; Gul N
    J Ayub Med Coll Abbottabad; 2018; 30(3):342-344. PubMed ID: 30465362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review.
    Berenguer J; Gómez-Campderá F; Padilla B; Rodríguez-Ferrero M; Anaya F; Moreno S; Valderrábano F
    Transplantation; 1998 May; 65(10):1401-4. PubMed ID: 9625028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From unexplained fever to visceral leishmaniasis--a case report].
    Marković I; Gudelj-Gracanin A; Culo MI; Stoos-Veić T; Vicković N; Desnica B; Morović-Vergles J
    Lijec Vjesn; 2014; 136(1-2):22-4. PubMed ID: 24720151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LD body-negative bone marrow cases of kala-azar in Dharan, Nepal.
    Karki P; Parija SC; Koirala S
    J Commun Dis; 1999 Dec; 31(4):261-2. PubMed ID: 10937305
    [No Abstract]   [Full Text] [Related]  

  • 8. [Leishmaniasis with cutaneous and visceral involvement in a 13-month old boy].
    Landmann E; Bogdan C; Donhauser N; Artlich A; Staude B; Gortner L
    Klin Padiatr; 2000; 212(5):266-7. PubMed ID: 11048286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Visceral leishmaniasis. Personal observation and review of epidemiology, clinical aspects and therapy].
    Dickerhoff R; Müller A; Bode U
    Klin Padiatr; 1990; 202(5):347-51. PubMed ID: 2170739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and Serological Evidence of Leishmania Infection in Stray Dogs from Visceral Leishmaniasis-Endemic Areas of Bangladesh.
    Akter S; Alam MZ; Nakao R; Yasin G; Kato H; Katakura K
    Am J Trop Med Hyg; 2016 Oct; 95(4):795-799. PubMed ID: 27382083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report.
    Lindoso JAL; Moreira CHV; Celeste BJ; Oyafuso LKM; Folegatti PM; Zijlstra EE
    Rev Soc Bras Med Trop; 2018; 51(1):105-107. PubMed ID: 29513829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and management of visceral leishmaniasis.
    Tanoli ZM; Rai ME; Gandapur AS
    J Ayub Med Coll Abbottabad; 2005; 17(4):51-3. PubMed ID: 16599036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus/Leishmania infantum in the first foci of urban American visceral leishmaniasis: clinical presentation from 1994 to 2010.
    Lima IP; Müller MC; Holanda TA; Harhay M; Costa CH; Costa DL
    Rev Soc Bras Med Trop; 2013; 46(2):156-60. PubMed ID: 23666663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of visceral leishmaniasis in India.
    Bora D
    Natl Med J India; 1999; 12(2):62-8. PubMed ID: 10416321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Images in clinical medicine. Kala-azar.
    Pantsari MW; Coleman TA
    N Engl J Med; 2003 Oct; 349(14):e13. PubMed ID: 14523156
    [No Abstract]   [Full Text] [Related]  

  • 18. [Visceral kala-azar of Spanish origin. Apropos of a case].
    De Caluwé JP; Lievens P; Trolin C; Heimann R; Delcourt A; Taelman H
    Acta Clin Belg; 1988; 43(5):349-55. PubMed ID: 3061269
    [No Abstract]   [Full Text] [Related]  

  • 19. Kala-azar in Orissa.
    Satapathy SK; Nanda BK
    J Indian Med Assoc; 1983 May; 80(9-10):144-5. PubMed ID: 6644053
    [No Abstract]   [Full Text] [Related]  

  • 20. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR.
    Manna M; Majumder HK; Sundar S; Bhaduri AN
    Med Sci Monit; 2005 Jul; 11(7):BR220-7. PubMed ID: 15990683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.